Menu
We use cookies to provide the best site experience.

AI platform for biomarker discovery

Discover the best outcome measurement for drug development

through blood biomarkers, wearables, and in-app functional tests

Features
There is a lack of “good” progression
biomarkers for genetic diseases
  • 1
    Progression biomarkers are extremely valuable for disease monitoring and drug testing
  • 2
    This limits the success rate of clinical trial studies and complicates drug development
  • 3
    Use of biomarkers in drug development can increase the likelihood of clinical trial success by about
    25-30%
Solution
Progression Biomarkers Discovery
OUR Tech
AI PLATFORM FOR BIOMARKER DISCOVERY
Meet Our Team
  • Nikita Konstantinovskiy
    CEO & Founder
  • Dima Smirnov
    CSO & Founder
Want to learn more about biomarker discovery with AI?
Get in touch with us!
nikkonst@jellyfish.bio